Information  X 
Enter a valid email address

Scancell Holdings PLC Ord 0.1P (SCLP)

Date Time Source Announcement
05 Oct 2018 7:00 am
RNS
Notice of AGM
25 Sep 2018 7:00 am
RNS
Final Results for the year ended 30 April 2018
18 Sep 2018 7:00 am
RNS
Notice of Final Results
10 Aug 2018 7:00 am
RNS
Board Change
09 Aug 2018 7:00 am
RNS
Agreement
25 Jul 2018 2:45 pm
RNS
Director/PDMR Shareholding
24 Jul 2018 7:00 am
RNS
Issue of Equity
18 Jul 2018 7:00 am
RNS
Scancell exercises TriGrid commercial option
23 May 2018 7:00 am
RNS
Grant of European patent for Moditope platform
11 May 2018 1:11 pm
RNS
Holding(s) in Company
  1:11 pm
RNS
Holding(s) in Company
09 May 2018 10:12 am
RNS
Holding(s) in Company
08 May 2018 7:00 am
RNS
Result of the Open Offer and PDMR Shareholdings
23 Apr 2018 12:43 pm
RNS
Holding(s) in Company
  12:43 pm
RNS
Holding(s) in Company
20 Apr 2018 4:32 pm
RNS
Holding(s) in Company
18 Apr 2018 2:29 pm
RNS
Result of Placing and Subscription and PDMR
  11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Proposed Placing, Subscription and Open Offer
  7:00 am
RNS
Technology acquired from University of Nottingham
03 Apr 2018 7:00 am
RNS
Manufacturing agreement with The PolyPeptide Group
16 Feb 2018 11:30 am
RNS
Scancell to present at the Calculus Investor Forum
15 Feb 2018 7:15 am
RNS
Hardman Res. - Validating multiple opportunities
  7:00 am
RNS
Collaboration agreement with ISA Pharmaceuticals
12 Feb 2018 7:00 am
RNS
Publication highlights potential of SCIB1 therapy
09 Feb 2018 7:00 am
RNS
European patent application allowed for grant
08 Feb 2018 7:00 am
RNS
Scancell member of team shortlisted for CRUK award
01 Feb 2018 7:00 am
RNS
Director/PDMR Shareholding
30 Jan 2018 7:00 am
RNS
Half-year Report
09 Jan 2018 7:00 am
RNS
Scancell to collaborate with BioNTech
14 Dec 2017 7:00 am
RNS
Scancell and CRUK to advance cancer immunotherapy
11 Oct 2017 9:44 am
RNS
Result of AGM
10 Oct 2017 7:00 am
RNS
Directorate Change
14 Sep 2017 7:00 am
RNS
Notice of AGM
13 Sep 2017 7:00 am
RNS
Final Results
11 Sep 2017 7:00 am
RNS
Presents Moditope Data at Immunotherapy Conference
29 Aug 2017 7:00 am
RNS
Oncimmune and Scancell Present Autoantibodies Data
11 Jul 2017 7:00 am
RNS
Continued Progress on SCIB1
26 Jun 2017 7:00 am
RNS
DNA ImmunoBody Patent Granted in Europe
22 May 2017 12:59 pm
RNS
Holding(s) in Company
  12:59 pm
RNS
Holding(s) in Company
19 May 2017 2:47 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
  7:00 am
RNS
Holding(s) in Company
11 May 2017 12:09 pm
RNS
Results of Placing
  7:00 am
RNS
Proposed Placing to Raise up to �5.0 million
13 Apr 2017 12:39 pm
RNS
Change of Registered Office
20 Mar 2017 7:00 am
RNS
Immuno-Oncology Summit Europe 2017
13 Mar 2017 7:15 am
RNS
Hardman Research: SCIB development update
01 Mar 2017 7:00 am
RNS
Holding(s) in Company
31 Jan 2017 7:00 am
RNS
Interim Results
30 Jan 2017 7:00 am
RNS
Partnership to Advance Lung Cancer Clinical Trials
03 Jan 2017 11:33 am
RNS
Research Update - Amendment
  7:00 am
RNS
Research Update
14 Nov 2016 7:00 am
RNS
World Immunotherapy Congress and Biotech and Money
18 Oct 2016 5:42 pm
RNS
Results of AGM
10 Oct 2016 7:00 am
RNS
Preparing SCIB2 for clinical study in lung cancer
26 Sep 2016 7:15 am
RNS
Hardman Report: New frontiers in T-cell activation
23 Sep 2016 5:24 pm
RNS
Notice of AGM - Amendment
 
Headlines
Top categories
Company finder
Forthcoming announcements

a d v e r t i s e m e n t